Keywords: ایمنوتراپی آلرژن; Allergen immunotherapy; ASIT; Basophil threshold sensitivity; CD63; CD203c;
مقالات ISI ایمنوتراپی آلرژن (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایمنوتراپی آلرژن; Food allergy; sensitization; tolerance; desensitization; sustained unresponsiveness; remission; allergen immunotherapy; microbiota; AD; Atopic dermatitis; Breg; Regulatory B; DC; Dendritic cell; EC; Epithelial cell; FoxP3; Forkhead box P3; ILC; Innate lym
Keywords: ایمنوتراپی آلرژن; IgE; immunoglobulin E; CAP; Immunoassay ImmunoCAP® Allergen; SACYL; Health Department of Castile and Leon Community; CRD; component resolved diagnosis; Eosinophilic esophagitis; Allergen immunotherapy; Component-resolved diagnosis; Pollen tube; Biopsy;
Keywords: ایمنوتراپی آلرژن; astma; alergiczny nieżyt nosa; immunoterapia alergenowa; efektywnoÅÄ; kosztów; Asthma; Allergic rhinitis; Allergen immunotherapy; Cost-effectiveness;
Keywords: ایمنوتراپی آلرژن; Allergen immunotherapy; Maintenance dose; Pollen season; Anaphylaxis; Side-effect; Immunothérapie allergénique; Dose d'entretien; Saison pollinique; Anaphylaxie; Effets secondaires;
Keywords: ایمنوتراپی آلرژن; Allergen immunotherapy; Tablet-based immunotherapy; Sublingual immunotherapy; Asthma; Allergic rhinitis; Respiratory allergy;
Keywords: ایمنوتراپی آلرژن; Airway hyperresponsiveness; Animal model; Bronchial asthma; House dust mites; Sublingual immunotherapy; AHR; airway hyperresponsiveness; AIT; allergen immunotherapy; BALF; bronchoalveolar lavage fluid; Der f; Dermatophagoides farinae; ELISA; enzyme-linked
Keywords: ایمنوتراپی آلرژن; Allergic rhinitis; Aspirin-exacerbated respiratory disease; Allergen immunotherapy; Immunoglobulin E;
Keywords: ایمنوتراپی آلرژن; Adrenaline; Allergen immunotherapy; Anaphylaxis; Epinephrine; Safety; Sublingual immunotherapy; Systemic allergic reaction; AE; Adverse event; AR/C; Allergic rhinitis with or without conjunctivitis; BAU; Bioequivalent allergen units; HDM; House dust mite;
Keywords: ایمنوتراپی آلرژن; Allergen immunotherapy; Mites; Pollens; Rhinoconjunctivitis; Asthma; Safety; Glutaraldehyde-modified allergen extracts;
Keywords: ایمنوتراپی آلرژن; Air quality; airway hyperreactivity; allergen immunotherapy; allergen sensitization; allergy; asthma; biomarkers; climate; chronic obstructive pulmonary disease; eosinophils; exacerbation; exhaled nitric oxide; genetics; ligelizumab; medication adherence;
Keywords: ایمنوتراپی آلرژن; Allergen challenge; allergen peptides; allergy; allergic rhinoconjunctivitis; allergic rhinitis; environmental exposure unit; epitope; grass; immunotherapy; synthetic peptide immunoregulatory epitope; AE; Adverse events; AIT; Allergen immunotherapy; ARC;
Keywords: ایمنوتراپی آلرژن; Sublingual; immunotherapy; ragweed; sublingual immunotherapy; AIT; Allergen immunotherapy; FDA; US Food and Drug Administration; PI; Package insert; SCIT; Subcutaneous immunotherapy; SLIT; Sublingual allergen immunotherapy;
Keywords: ایمنوتراپی آلرژن; Allergen immunotherapy; Adherence; Patient-centered care; Shared decision making; Motivational interviewing;
Keywords: ایمنوتراپی آلرژن; AD; Atopic dermatitis; AIT; Allergen immunotherapy; AR; Allergic rhinitis; DBPC; Double-blind, placebo-controlled; EASI; Eczema Area and Severity Index; GRADE; Grading of Recommendations Assessment, Development, and Evaluation; HDM; House dust mite; RCT;
Keywords: ایمنوتراپی آلرژن; Allergic rhinitis; Type 1 hypersensitivity; Vasomotor rhinitis; Skin prick testing; Serum-specific Ig E; Allergen immunotherapy; Chronic rhinosinusitis; Nasal polyps;
Keywords: ایمنوتراپی آلرژن; Allergen immunotherapy; allergic rhinoconjunctivitis; ragweed; grass; house dust mite; sublingual immunotherapy tablet; intranasal corticosteroid; antihistamine; leukotriene receptor antagonists; meta-analysis; AIT; Allergy immunotherapy; AR; Allergic rhi
Keywords: ایمنوتراپی آلرژن; Subcutaneous immunotherapy; Sublingual immunotherapy; Indications; Allergen immunotherapy; Efficacy; Safety; History; Molecular diagnosis;
Keywords: ایمنوتراپی آلرژن; Local allergic rhinitis; Asthma; Nasal allergen provocation test; Local IgE; Natural evolution; Allergen immunotherapy;
Keywords: ایمنوتراپی آلرژن; Anaphylaxis; atopic dermatitis; asthma; eosinophilia; allergen immunotherapy; AD; Atopic dermatitis; ADR; TÂ cell-mediated adverse drug reaction; AIT; Allergen immunotherapy; BATF; Basic leucine zipper transcription factor; CHS; Contact hypersensitivity
Keywords: ایمنوتراپی آلرژن; Allergic rhinitis; Allergen immunotherapy; Vaccine modification;
Keywords: ایمنوتراپی آلرژن; Allergen immunotherapy; Practice parameters; Practice guidelines; Immunotherapy labeling; Allergen extracts; Student health services; Adherence; Health services research; AIT; Allergen immunotherapy; CC; Color coding; Exp; expiration date; OR; Odds ratio;
Keywords: ایمنوتراپی آلرژن; Conjunctival allergen challenge; Rhinoconjunctivitis; Outcome parameter; Sublingual immunotherapy; AIT; Allergen immunotherapy; AR; Allergic rhinoconjunctivitis; CPT; Conjunctival provocation test; dSS; Daily symptom score; DWD; Deutscher Wetterdienst; EM
Keywords: ایمنوتراپی آلرژن; Environmental exposure chamber; allergen immunotherapy; clinical validation; pivotal studies; AIT; Allergen immunotherapy; AR; Allergic rhinitis; ARTSS; Average rhinoconjunctivitis total symptom score; EEC; Environmental exposure chamber; EMA; European Me
Keywords: ایمنوتراپی آلرژن; Food allergy; immunotherapy; anti-IgE; oral tolerance; allergen sensitization; anaphylaxis; biologics; AIT; Allergen immunotherapy; DARPin; Designed ankyrin repeat protein; DC; Dendritic cell; EC; Epithelial cell; EoE; Eosinophilic esophagitis; Foxp3; For
Keywords: ایمنوتراپی آلرژن; Allergen immunotherapy; allergic rhinoconjunctivitis; house dust mite; sublingual immunotherapy tablet; dose response; dose related; onset of action; environmental exposure chamber; nasal symptoms; ocular symptoms; AAR; Active anterior rhinomanometry; AE;
Keywords: ایمنوتراپی آلرژن; Diamine oxidase; basophils; allergen immunotherapy; sublingual immunotherapy; subcutaneous immunotherapy; histamine; basophil activation assay; CRTh2; Chemoattractant receptor-homologous molecule expressed on TH2 lymphocytes; DAO; Diamine oxidase; NAC; No
Keywords: ایمنوتراپی آلرژن; Immunotherapy; allergy; asthma; omalizumab; allergens; recombinant; peptide; epicutaneous; intraepithelial; sublingual immunotherapy; AIT; Allergen immunotherapy; ILIT; Intralymphatic immunotherapy; MATA; Modified allergen tyrosine absorbate; MPL; Monopho
Keywords: ایمنوتراپی آلرژن; Regulatory T cells; immunotherapy; IgE; T cells; IL-10; TGF-β; allergen immunotherapy; T helper cells; immune tolerance; IgE; IgG; T cells; B cells; mast cells; basophils; eosinophils; AIT; Allergen-specific immunotherapy; BR1; IL-10-secreting regulato
Keywords: ایمنوتراپی آلرژن; Allergic rhinitis; double-blind; placebo-controlled; sublingual immunotherapy tablets; house dust mite; AAdSS; Average Adjusted Symptom Score; AdSS; Adjusted Symptom Score; AIT; Allergen immunotherapy; AR; Allergic rhinitis; ARMS; Average Rescue Medicatio
Specific allergy and asthma prevention coming to an age: AÂ milestone in children
Keywords: ایمنوتراپی آلرژن; Allergen immunotherapy; grass tablet; children; disease-modifying effect; asthma prevention;
Phenotype analyses of IL-10-producing Foxp3â CD4+ T cells increased by subcutaneous immunotherapy in allergic airway inflammation
Keywords: ایمنوتراپی آلرژن; Airway inflammation; Allergen immunotherapy; Interleukin-10; Regulatory T cell; Th2 cell; Type 1 regulatory T cell;
Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32
Keywords: ایمنوتراپی آلرژن; Allergy; grass pollen allergy; allergen; allergen immunotherapy; recombinant allergen; B-cell epitope-based immunotherapy; efficacy; hypoallergenic; clinical trial; safety; AE; Adverse event; AIT; Allergen immunotherapy; API; Active pharmaceutical ingre
The role of active B cells in allergen immunotherapy
Keywords: ایمنوتراپی آلرژن; CD23; Allergen immunotherapy; Autoimmunity; B cells; Allergic asthma; Allergic rhinitis;
Allergie aux acariens. Diagnostic, prise en charge et modalités de l'ITA chez les patients poly-allergiques
Keywords: ایمنوتراپی آلرژن; Immunothérapie allergénique; Allergie; Poly-allergie; Polysensibilisation; Qualité de vie; Allergen immunotherapy; Allergy; Multiple allergy; Multi-sensitization; Quality of life;
Transcutaneous immunotherapy of pollinosis using solid-in-oil nanodispersions loaded with T cell epitope peptides
Keywords: ایمنوتراپی آلرژن; IgE; Immunoglobulin E; AIT; Allergen immunotherapy; SCIT; Subcutaneous immunotherapy; SLIT; Sublingual immunotherapy; TCIT; Transcutaneous immunotherapy; SC; Stratum corneum; S/O; Solid-in-oil; FITC; Fluorescein-4-isothiocyanate; Rho-DOPE; Rhodamine-diole
Validation of the Global Allergy and Asthma European Network (GA2LEN) chamber for trials in allergy: Innovation of a mobile allergen exposure chamber
Keywords: ایمنوتراپی آلرژن; Allergy trial; environmental exposure chamber; validation; grasses; placebo; Global Allergy and Asthma European Network (GA2LEN); AIT; Allergen immunotherapy; AUC; Area under the curve; EEC; Environmental exposure chamber; GA2LEN; Global Allergy and Asthm
Japanese guidelines for allergic rhinitis 2017
Keywords: ایمنوتراپی آلرژن; Allergen immunotherapy; Mechanism; Pharmacotherapy; Pollinosis; Surgery;
Specific IgE and IgG measured by the MeDALL allergen-chip depend on allergen and route of exposure: The EGEA study
Keywords: ایمنوتراپی آلرژن; IgE; IgG; allergen components; respiratory allergens; food allergens; EGEA; cohort; epidemiology; MeDALL; microarray; AIT; Allergen immunotherapy; Bet v; Betula verrucosa; EGEA; Epidemiological study of the Genetics and Environment of Asthma, bronchial hy
Dendritic cell targeting with C-type lectins for improvement of allergen immunotherapy
Keywords: ایمنوتراپی آلرژن; Dendritic cells; targeting; mannan; C-type lectins; allergen immunotherapy;
Longitudinal profiles of serum specific IgE and IgG4 to Dermatophagoides pteronyssinus allergen and its major components during allergen immunotherapy in a cohort of southern Chinese children
Keywords: ایمنوتراپی آلرژن; Allergen immunotherapy; House dust mite; Dermatophagoides pteronyssinus; Allergen components; Specific IgE; Specific IgG4
Specific allergen immunotherapy attenuates allergic airway inflammation in a rat model of Alstonia scholaris pollen induced airway allergy
Keywords: ایمنوتراپی آلرژن; Alstonia scholaris pollen; Airway allergy; Allergen immunotherapy; Pollen allergy; Rat model
Role of regulatory B cells in immune tolerance to allergens and beyond
Keywords: ایمنوتراپی آلرژن; Regulatory B cells; IL-10; IL-35; TGF-β; IgG4; tolerance; allergen; autoimmunity; suppression; BR1; B10; AIT; Allergen immunotherapy; BCR; B-cell receptor; Breg; Regulatory B; DC; Dendritic cell; EAE; Experimental autoimmune encephalomyelitis; MZ; Margin
Mechanisms of allergy and clinical immunologyChanges in markers associated with dendritic cells driving the differentiation of either TH2 cells or regulatory T cells correlate with clinical benefit during allergen immunotherapy
Keywords: ایمنوتراپی آلرژن; Allergen; biomarker; dendritic cell; monocyte; sublingual immunotherapy; AIT; Allergen immunotherapy; ANR; Active nonresponder; AR; Active responder; ARTSS; Average rhinoconjunctivitis total symptom score; C1QA; Complement C1q subcomponent subunit A; Ctrl
Coseasonal Initiation of Allergen Immunotherapy: A Systematic Review
Keywords: ایمنوتراپی آلرژن; Allergen immunotherapy; Allergic rhinoconjunctivitis; Co-seasonal; In-season; Initiation; Intra-seasonal; Safety; AE; adverse event; AIT; Allergen immunotherapy; DBPC; double-blind, placebo-controlled; RCT; randomized controlled trial; SCIT; subcutaneous
Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: Results from a randomized, double-blind, placebo-controlled phase III trial
Keywords: ایمنوتراپی آلرژن; Allergy immunotherapy; sublingual immunotherapy tablet; sublingual immunotherapy; allergen immunotherapy; allergy; allergic rhinitis; house dust mite; Rhinitis Quality of Life Questionnaire; rhinoconjunctivitis; total combined rhinitis score; AE; Adverse
Rhinitis, sinusitis, and upper airway diseaseShort-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: AÂ randomized controlled trial
Keywords: ایمنوتراپی آلرژن; Allergic rhinitis; subcutaneous allergen immunotherapy; anti-IL-4; FluoroSpot; intradermal late-phase response; AE; Adverse event; AIT; Allergen immunotherapy; Cmax; Maximum drug plasma concentration; CRTH2; Chemoattractant receptor-homologous molecule
Novel vaccines targeting dendritic cells by coupling allergoids to nonoxidized mannan enhance allergen uptake and induce functional regulatory TÂ cells through programmed death ligand 1
Keywords: ایمنوتراپی آلرژن; Allergen immunotherapy; vaccines; neoglycans; allergoids; mannan; immunomodulation; dendritic cells; regulatory TÂ cells; AIT; Allergen immunotherapy; APC; Allophycocyanin; BAT; Basophil activation test; CFSE; Carboxyfluorescein succinimidyl ester; CLR; C
Characterisation of systemic reactions to subcutaneous immunotherapy with airborne allergens and classification according to WAO 2010
Keywords: ایمنوتراپی آلرژن; Allergen immunotherapy; Classification; Systemic reactions
Mechanisms of allergy and clinical immunologyIdentification of the cysteine protease Amb a 11 as a novel major allergen from short ragweed
Keywords: ایمنوتراپی آلرژن; Allergen; Amb a 11; Ambrosia artemisiifolia; cysteine protease; mass spectrometry; short ragweed; AIT; Allergen immunotherapy; 2D; Two-dimensional; IUIS; International Union of Immunological Societies; MS; Mass spectrometry; MS/MS; Tandem mass spectrometr